Insider · CIK 0001421162

Galen Management, LLC

CIK 0001421162 Name as filed on the most recent filing

Filed as Galen Management, LLC (39)

69 transaction lines · from 39 filings · filed 2009-09-17 to 2018-01-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-12-14 S, Open-market sale Acura Pharmaceuticals, IncACUR 219,573, disposed Open Form 4 filing 0001209191-18-000346
2017-09-15 S, Open-market sale Tactile Systems Technology IncTCMD 86,685,390, disposed Open Form 4 filing 0001209191-17-053313
2017-06-28 S, Open-market sale Tactile Systems Technology IncTCMD 5,770,000, disposed Open Form 4 filing 0001209191-17-042333
2017-06-21 S, Open-market sale Tactile Systems Technology IncTCMD 2,195,350, disposed Open Form 4 filing 0001209191-17-041443
2017-06-13 S, Open-market sale Tactile Systems Technology IncTCMD 7,386,375, disposed Open Form 4 filing 0001209191-17-039838
2017-06-01 S, Open-market sale Tactile Systems Technology IncTCMD 5,000,000, disposed Open Form 4 filing 0001209191-17-037171
2017-05-11 S, Open-market sale Tactile Systems Technology IncTCMD 6,906,250, disposed Open Form 4 filing 0001209191-17-032529
2017-05-11 S, Open-market sale Tactile Systems Technology IncTCMD 6,906,250, acquired Open Form 4 filing 0001209191-17-032368
2016-08-03 P, Open-market purchase Quotient LtdQTNT 990,000, acquired Open Form 4 filing 0001209191-16-135723
2016-02-10 P, Open-market purchase Quotient LtdQTNT 1,999,998, acquired Open Form 4 filing 0001209191-16-098106
2015-06-17 S, Open-market sale Acura Pharmaceuticals, IncACUR 4,095, disposed Open Form 4 filing 0001209191-15-054770
2015-06-16 S, Open-market sale Acura Pharmaceuticals, IncACUR 109,441, disposed Open Form 4 filing 0001209191-15-054770
2015-01-12 S, Open-market sale Acura Pharmaceuticals, IncACUR 22,456, disposed Open Form 4 filing 0001209191-15-006524
2015-01-12 S, Open-market sale Acura Pharmaceuticals, IncACUR 22,456, disposed Open Form 4 filing 0001209191-15-003773
2015-01-09 S, Open-market sale Acura Pharmaceuticals, IncACUR 23,436, disposed Open Form 4 filing 0001209191-15-006524
2015-01-09 S, Open-market sale Acura Pharmaceuticals, IncACUR 23,436, disposed Open Form 4 filing 0001209191-15-003773
2015-01-08 S, Open-market sale Acura Pharmaceuticals, IncACUR 60,180, disposed Open Form 4 filing 0001209191-15-006524
2015-01-08 S, Open-market sale Acura Pharmaceuticals, IncACUR 60,180, disposed Open Form 4 filing 0001209191-15-003773
2014-11-28 P, Open-market purchase Quotient LtdQTNT 1,500,003, acquired Open Form 4 filing 0001209191-14-071984
2014-04-30 P, Open-market purchase Quotient LtdQTNT 2,500,000, acquired Open Form 4 filing 0001209191-14-030432
2014-03-03 S, Open-market sale Acura Pharmaceuticals, IncACUR 5,000, disposed Open Form 4 filing 0001209191-14-017134
2014-02-28 S, Open-market sale Acura Pharmaceuticals, IncACUR 43,321, disposed Open Form 4 filing 0001209191-14-022631
2014-02-28 S, Open-market sale Acura Pharmaceuticals, IncACUR 295,756, disposed Open Form 4 filing 0001209191-14-015475
2014-02-27 S, Open-market sale Acura Pharmaceuticals, IncACUR 392,946, disposed Open Form 4 filing 0001209191-14-015475
2014-02-26 S, Open-market sale Acura Pharmaceuticals, IncACUR 2 lines 22,067, disposed Open Form 4 filing 0001209191-14-015475
2014-02-24 S, Open-market sale Acura Pharmaceuticals, IncACUR 86,024, disposed Open Form 4 filing 0001209191-14-014103
2014-02-21 S, Open-market sale Acura Pharmaceuticals, IncACUR 530, disposed Open Form 4 filing 0001209191-14-014103
2014-02-18 S, Open-market sale Acura Pharmaceuticals, IncACUR 4,290, disposed Open Form 4 filing 0001209191-14-012427
2013-10-10 S, Open-market sale Acura Pharmaceuticals, IncACUR 8,610, disposed Open Form 4 filing 0001209191-13-048236
2013-07-02 S, Open-market sale Acura Pharmaceuticals, IncACUR 430,000, disposed Open Form 4 filing 0001209191-13-035727
2013-06-17 S, Open-market sale Acura Pharmaceuticals, IncACUR 43,959, disposed Open Form 4 filing 0001209191-13-032999
2013-06-14 S, Open-market sale Acura Pharmaceuticals, IncACUR 59,800, disposed Open Form 4 filing 0001209191-13-032295
2013-06-12 S, Open-market sale Acura Pharmaceuticals, IncACUR 7,632, disposed Open Form 4 filing 0001209191-13-032295
2013-06-10 S, Open-market sale Acura Pharmaceuticals, IncACUR 21,437, disposed Open Form 4 filing 0001209191-13-031650
2013-06-07 S, Open-market sale Acura Pharmaceuticals, IncACUR 25,833, disposed Open Form 4 filing 0001209191-13-031650
2013-06-06 S, Open-market sale Acura Pharmaceuticals, IncACUR 21,302, disposed Open Form 4 filing 0001209191-13-031238
2013-06-05 S, Open-market sale Acura Pharmaceuticals, IncACUR 14,697, disposed Open Form 4 filing 0001209191-13-031238
2013-06-04 S, Open-market sale Acura Pharmaceuticals, IncACUR 50,392, disposed Open Form 4 filing 0001209191-13-031238
2013-05-31 S, Open-market sale Acura Pharmaceuticals, IncACUR 42,073, disposed Open Form 4 filing 0001209191-13-030248
2013-05-30 S, Open-market sale Acura Pharmaceuticals, IncACUR 29,012, disposed Open Form 4 filing 0001209191-13-030248
2013-05-21 S, Open-market sale Acura Pharmaceuticals, IncACUR 108,977, disposed Open Form 4 filing 0001209191-13-028548
2013-05-20 S, Open-market sale Acura Pharmaceuticals, IncACUR 165,231, disposed Open Form 4 filing 0001209191-13-027656
2013-05-17 S, Open-market sale Acura Pharmaceuticals, IncACUR 128,291, disposed Open Form 4 filing 0001209191-13-027656
2013-05-16 S, Open-market sale Acura Pharmaceuticals, IncACUR 94,093, disposed Open Form 4 filing 0001209191-13-027656
2013-05-15 S, Open-market sale Acura Pharmaceuticals, IncACUR 53,606, disposed Open Form 4 filing 0001209191-13-026544
2013-05-14 S, Open-market sale Acura Pharmaceuticals, IncACUR 213,227, disposed Open Form 4 filing 0001209191-13-026544
2013-05-13 S, Open-market sale Acura Pharmaceuticals, IncACUR 160,057, disposed Open Form 4 filing 0001209191-13-026544
2013-05-07 S, Open-market sale Acura Pharmaceuticals, IncACUR 46,651, disposed Open Form 4 filing 0001209191-13-024696
2013-05-06 S, Open-market sale Acura Pharmaceuticals, IncACUR 223,594, disposed Open Form 4 filing 0001209191-13-024696

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Galen Management, LLC, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001421162

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.